Clinical trials
Observational Uterine Cervical Dysplasia trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2011 | 1 |
| 2015 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2021 | 5 |
| 2022 | 4 |
| 2023 | 1 |
| 2024 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 11 |
| Active, not recruiting | 3 |
| Completed | 3 |
| Not yet recruiting | 2 |
| Enrolling by invitation | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Jun Zhang | 4 |
| Huazhong University of Science and Technology | 2 |
| Lei Li | 2 |
| Peking University People's Hospital | 2 |
| Shanghai Zerun Biotechnology Co.,Ltd | 2 |
| Fujian Maternity and Child Health Hospital | 1 |
| GlaxoSmithKline | 1 |
| National Cancer Institute (NCI) | 1 |
| Peking Union Medical College Hospital | 1 |
| Shufang Chang | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Uterine Cervical Dysplasia | 21 |
| Uterine Cervical Neoplasms | 16 |
| Papillomavirus Infections | 7 |
| Persistent Infection | 5 |
| Squamous Intraepithelial Lesions | 4 |
| Adenocarcinoma in Situ | 2 |
| Atypical Squamous Cells of the Cervix | 2 |
| Margins of Excision | 1 |
| Neoplasms | 1 |
| Recurrence | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.